Literature DB >> 8405748

Different effects of glucose and glyburide on insulin secretion in rat pancreatic islets pre-exposed to interleukin-1 beta. Possible involvement of K+ and Ca2+ channels.

M Buscema1, A M Rabuazzo, C Vinci, V Caltabiano, R Vigneri, F Purrello.   

Abstract

In vitro islet exposure to interleukin 1 beta inhibits the beta-cell response to glucose. We have studied whether a similar inhibition also occurs in response to the sulphonylurea glyburide. Rat pancreatic islets were cultured for 24 h in the presence or absence of 50 U/ml interleukin 1 beta and then stimulated with either glucose or glyburide for 1 h at 37 degrees C. In control islets basal insulin secretion was 117 +/- 32 pg.islet-1.h-1 (mean +/- SEM, n = 7) and greatly increased in response to 16.7 mmol/l glucose (2140 +/- 293) or 10 mumol/l glyburide (1464 +/- 234). When islets were pre-exposed to interleukin 1 beta, insulin release was significantly reduced in response to glucose (323 +/- 80, p < 0.001) but not in response to glyburide (1316 +/- 185). Since both glucose and glyburide influence beta-cell K+ and Ca2+ efflux, to further investigate this different response in islets exposed to interleukin 1 beta we measured both Rb+ efflux (as index of the ATP-sensitive K+ channel activity) and Ca2+ uptake. In control islets, the increased insulin secretion in response to 16.7 mmol/l glucose or 10 mumol/l glyburide was associated with a reduction of 86Rb efflux (decrement of -50 +/- 1.2% and -49 +/- 2.3%, respectively, mean +/- SEM, n = 5). In contrast, in interleukin 1 beta pre-exposed islets both glucose and glyburide stimulation only slightly modified 86Rb efflux (decrement of -19 +/- 1.9% and -5.3 +/- 3.1%, respectively, n = 5, p < 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405748     DOI: 10.1007/bf00400351

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  31 in total

1.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

2.  Studies in prediabetes. Insulin response to oral glucose, intravenous tolbutamide and rapid intravenous glucose infusion in genetic prediabetics.

Authors:  M Serrano-Rios; F Ramos; J L Rodriguez-Miñon; F Vivanco
Journal:  Diabetologia       Date:  1970-08       Impact factor: 10.122

3.  Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans.

Authors:  T Mandrup-Poulsen; K Bendtzen; J Nerup; C A Dinarello; M Svenson; J H Nielsen
Journal:  Diabetologia       Date:  1986-01       Impact factor: 10.122

4.  Cytokines cause functional and structural damage to isolated islets of Langerhans.

Authors:  T Mandrup-Poulsen; K Bendtzen; J H Nielsen; G Bendixen; J Nerup
Journal:  Allergy       Date:  1985-08       Impact factor: 13.146

5.  Modulation of dihydropyridine-sensitive Ca2+ channels by glucose metabolism in mouse pancreatic beta-cells.

Authors:  P A Smith; P Rorsman; F M Ashcroft
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

6.  Correlations of in vivo beta-cell function tests with beta-cell mass and pancreatic insulin content in streptozocin-administered baboons.

Authors:  D K McCulloch; D J Koerker; S E Kahn; S Bonner-Weir; J P Palmer
Journal:  Diabetes       Date:  1991-06       Impact factor: 9.461

7.  Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cells.

Authors:  J C Henquin; H P Meissner
Journal:  Biochem Pharmacol       Date:  1982-04-01       Impact factor: 5.858

8.  Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus.

Authors:  O P Ganda; S Srikanta; S J Brink; M A Morris; R E Gleason; J S Soeldner; G S Eisenbarth
Journal:  Diabetes       Date:  1984-06       Impact factor: 9.461

9.  Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.

Authors:  A M Rabuazzo; M Buscema; C Vinci; V Caltabiano; M Vetri; F Forte; R Vigneri; F Purrello
Journal:  Endocrinology       Date:  1992-10       Impact factor: 4.736

10.  Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.

Authors:  S Sandler; K Bendtzen; L A Borg; D L Eizirik; E Strandell; N Welsh
Journal:  Endocrinology       Date:  1989-03       Impact factor: 4.736

View more
  2 in total

1.  Interleukin-1 beta inhibition of insulin release in rat pancreatic islets: possible involvement of G-proteins in the signal transduction pathway.

Authors:  A M Rabuazzo; M Buscema; V Caltabiano; M Anello; C Degano; G Patanè; R Vigneri; F Purrello
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

2.  Copper addition prevents the inhibitory effects of interleukin 1-beta on rat pancreatic islets.

Authors:  C Vinci; V Caltabiano; A M Santoro; A M Rabuazzo; M Buscema; R Purrello; E Rizzarelli; R Vigneri; F Purrello
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.